Loading…

Medical Research Finder

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Breast Cancer / Mammacarcinoma (TNBC)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Stage I–III triple-negative breast cancer accounts for approximately 15–20% of new diagnoses of early breast cancer
Rizzo et al. 2022a Future Oncology 18: 2301-2309

Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive malignancy. Characteristic is the absence of Estrogen receptors and [Progesterone receptors](brai…

Emerging PARP inhibitors for treating breast cancer
Robert et al. 2018a Expert Opin. Emerging Drugs 23: 211-221
Review
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.
Saraiva et al. 2017 ESMO Open 2: e000208
Review
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer
Rizzo et al. 2022a Future Oncology 18: 2301-2309
Review
Research progress on immunotherapy in triple‑negative breast cancer (Review)
Zhang et al. 2022e International Journal of Oncology 61: 95
Review

12/16/2025